Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

NCT04468360 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Post Traumatic Stress Disorder

Interventions

BEHAVIORAL: 3-day differential fear conditioning, extinction, and extinction retention testing paradigm
DRUG: Allopregnanolone (Allo) with Dexolve in 0.9% saline for injection manufactured by University of California, Davis
OTHER: Matching IV Placebo

Sponsor

Boston University

Collaborators

[object Object]